Meta AnalysisID 5506

非维生素K拮抗剂口服抗凝药与华法林治疗心房颤动患者的传统和网状Meta分析:一项更新Meta分析

CRD42022347031

Patients suffering from atrial fibrillation (AF) were taking higher risk of embolism and stroke. And previous clinical study have shown that asundexian would be better choice for AF patients. To compare and recommend the

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
5506
Evidence Id
14064
Core Evidence Id
14064
Source Meta Analysis Id
5491
Herb2 Meta Analysis Id
HBMA005491
Crd Id
CRD42022347031
Title
A conventional and network meta-analysis on non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation, an updated meta-analysis
Review Question
Patients suffering from atrial fibrillation (AF) were taking higher risk of embolism and stroke. And previous clinical study have shown that asundexian would be better choice for AF patients. To compare and recommend the better anticoagulant for patients with AF, we performed the conventional and network meta-analysis comparing non-vitamin K antagonist oral anticoagulants to warfarin for preventing stroke or embolism and bleeding in patients.
Study Type Included
Studies enrolled had to be a phase lll or lV randomized controlled trial.
Condition Being Studied
Participant
Animal
Human Disease Modelled
Intervention
Patients treated with non-vitamin K antagonist oral anticoagulants including dabigatran, edoxaban, apixaban rivaroxaban and asundexian
Comparator Control
Patients treated with warfarin
Main Outcome
Outcome Measure
Additional Outcome
Study Method
Meta-analysis, Network meta-analysis, Systematic review
Keyword
Anticoagulants; Atrial Fibrillation; Humans; Network Meta-Analysis; Stroke; Warfarin
Contact
Organisational Affiliation
Funding Source
Other Selection Criteria
Final Publication
Same Topic Review
Published Protocol
Review Type
Language
English
Country
China
Review Stage
First Submission Date
Registration Date
2022-07-27
Anticipated Start Date
Anticipated Completion Date
Title Cn
非维生素K拮抗剂口服抗凝药与华法林治疗心房颤动患者的传统和网状Meta分析:一项更新Meta分析
Title En
A conventional and network meta-analysis on non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation, an updated meta-analysis
Bilingual Status
complete